Exploring the glycosylation of serum CA125

International Journal of Molecular Sciences

Volumn 14, Issue 8, 2013, Pages 15636-15654

  Saldova, Radka ^a   Struwe, Weston B ^a   Wynne, Kieran ^b   Elia, Giuliano ^b   Duffy, Michael J ^b,c   Rudd, Pauline M ^a  

^a NATIONAL INSTITUTE FOR BIOPROCESSING RESEARCH AND TRAINING   (Ireland)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

^c ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

Author keywords

Biomarker; CA125; N glycosylation; Ovarian cancer

Indexed keywords

BIOLOGICAL MARKER; CA 125 ANTIGEN; FUCOSE; GALACTOSE; MANNOSE; N ACETYLGALACTOSAMINE; N ACETYLGLUCOSAMINE; SIALIC ACID;

ADULT; AGED; ANTIGEN PURIFICATION; ARTICLE; CARBOHYDRATE ANALYSIS; CONTROLLED STUDY; CROSS REACTION; DOWN REGULATION; FEMALE; GLYCOSYLATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYDROPHILIC INTERACTION CHROMATOGRAPHY; OVARY CANCER; POLYACRYLAMIDE GEL ELECTROPHORESIS; SERUM; UPREGULATION; WESTERN BLOTTING;

BIOLOGICAL MARKERS; CA-125 ANTIGEN; CARBOHYDRATE SEQUENCE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; FUCOSE; GLYCOSYLATION; HUMANS; MOLECULAR SEQUENCE DATA; OVARIAN NEOPLASMS; POLYSACCHARIDES; TANDEM MASS SPECTROMETRY;

EID: 84881038609     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms140815636     Document Type: Article

References (43)

1. Zhang, B.; Cai, F.F.; Zhong, X.Y. An overview of biomarkers for the ovarian cancer diagnosis. Eur. J. Obstet. Gynecol. Reprod. Biol. 2011, 158, 119-123.
2. Scholler, N.; Urban, N. CA125 in ovarian cancer. Biomark Med. 2007, 1, 513-523.
3. Storr, S.J.; Royle, L.; Chapman, C.J.; Hamid, U.M.; Robertson, J.F.; Murray, A.; Dwek, R.A.; Rudd, P.M. The O-linked glycosylation of secretory/shed MUC1 from an advanced breast cancer patient's serum. Glycobiology 2008, 18, 456-462.
4. Gilgunn, S.; Conroy, P.J.; Saldova, R.; Rudd, P.M.; O'Kennedy, R.J. Aberrant PSA glycosylation-a sweet predictor of prostate cancer. Nat. Rev. Urol. 2012, 10, 99-107.
5. Bast, R.C., Jr.; Feeney, M.; Lazarus, H.; Nadler, L.M.; Colvin, R.B.; Knapp, R.C. Reactivity of a monoclonal antibody with human ovarian carcinoma. J. Clin. Invest. 1981, 68, 1331-1337.
6. Yin, B.W.; Lloyd, K.O. Molecular cloning of the CA125 ovarian cancer antigen: Identification as a new mucin, MUC16. J. Biol. Chem. 2001, 276, 27371-27375.
7. Rump, A.; Morikawa, Y.; Tanaka, M.; Minami, S.; Umesaki, N.; Takeuchi, M.; Miyajima, A. Binding of ovarian cancer antigen CA125/MUC16 to mesothelin mediates cell adhesion. J. Biol. Chem. 2004, 279, 9190-9198.
8. O'Brien, T.J.; Beard, J.B.; Underwood, L.J.; Dennis, R.A.; Santin, A.D.; York, L. The CA 125 gene: An extracellular superstructure dominated by repeat sequences. Tumour Biol. 2001, 22, 348-366.
9. Kui Wong, N.; Easton, R.L.; Panico, M.; Sutton-Smith, M.; Morrison, J.C.; Lattanzio, F.A.; Morris, H.R.; Clark, G.F.; Dell, A.; Patankar, M.S. Characterization of the oligosaccharides associated with the human ovarian tumor marker CA125. J. Biol. Chem. 2003, 278, 28619-28634.
10. Weiland, F.; Martin, K.; Oehler, M.K.; Hoffmann, P. Deciphering the Molecular Nature of Ovarian Cancer Biomarker CA125. Int. J. Mol. Sci. 2012, 13, 10568-10582.
11. Seelenmeyer, C.; Wegehingel, S.; Lechner, J.; Nickel, W. The cancer antigen CA125 represents a novel counter receptor for galectin-1. J. Cell Sci. 2003, 116, 1305-1318.
12. Gaetje, R.; Winnekendonk, D.W.; Scharl, A.; Kaufmann, M. Ovarian cancer antigen CA 125 enhances the invasiveness of the endometriotic cell line EEC 145. J. Soc. Gynecol. Investig. 1999, 6, 278-281.
13. Milutinovic, B.; Jankovic, M. Analysis of the protein and glycan parts of CA125 antigen from human amniotic fluid. Arch. Biol. Sci. 2007, 59, 97-103.
14. Jankovic, M.M.; Tapuskovic, B.S. Molecular forms and microheterogeneity of the oligosaccharide chains of pregnancy-associated CA125 antigen. Hum. Reprod. 2005, 20, 2632-2638.
15. Barrabes, S.; Pages-Pons, L.; Radcliffe, C.M.; Tabares, G.; Fort, E.; Royle, L.; Harvey, D.J.; Moenner, M.; Dwek, R.A.; Rudd, P.M.; et al. Glycosylation of serum ribonuclease 1 indicates a major endothelial origin and reveals an increase in core fucosylation in pancreatic cancer. Glycobiology 2007, 17, 388-400.
16. Tabares, G.; Radcliffe, C.M.; Barrabes, S.; Ramirez, M.; Aleixandre, R.N.; Hoesel, W.; Dwek, R.A.; Rudd, P.M.; Peracaula, R.; de Llorens, R. Different glycan structures in prostate-specific antigen from prostate cancer sera in relation to seminal plasma PSA. Glycobiology 2006, 16, 132-145.
17. Peter, J.; Unverzagt, C.; Lenz, H.; Hoesel, W. Purification of prostate-specific antigen from human serum by indirect immunosorption and elution with a hapten. Anal. Biochem. 1999, 273, 98-104.
18. Royle, L.; Campbell, M.P.; Radcliffe, C.M.; White, D.M.; Harvey, D.J.; Abrahams, J.L.; Kim, Y.G.; Henry, G.W.; Shadick, N.A.; Weinblatt, M.E.; et al. HPLC-based analysis of serum N-glycans on a 96-well plate platform with dedicated database software. Anal. Biochem. 2008, 376, 1-12.
19. Harvey, D.J.; Merry, A.H.; Royle, L.; Campbell, M.P.; Dwek, R.A.; Rudd, P.M. Proposal for a standard system for drawing structural diagrams of N- and O-linked carbohydrates and related compounds. Proteomics 2009, 9, 3796-3801.
20. Peracaula, R.; Tabares, G.; Royle, L.; Harvey, D.J.; Dwek, R.A.; Rudd, P.M.; de Llorens, R. Altered glycosylation pattern allows the distinction between prostate-specific antigen (PSA) from normal and tumor origins. Glycobiology 2003, 13, 457-470.
21. Peracaula, R.; Royle, L.; Tabares, G.; Mallorqui-Fernandez, G.; Barrabes, S.; Harvey, D.J.; Dwek, R.A.; Rudd, P.M.; de Llorens, R. Glycosylation of human pancreatic ribonuclease: differences between normal and tumor states. Glycobiology 2003, 13, 227-244.
22. Varki, A.; Lowe, J.B. Exploring the Biological Roles of Glycans. In Essentials of Glycobiology; Varki, A., Cummings, R.D., Esko, J.D., Freeze, H.H., Stanley, P., Bertozzi, C.R., Hart, G.W., Etzler, M.E., Eds.; Cold Spring Laboratory Press: Cold Spring Harbor, NY, USA, 2009; pp. 57-68.
23. Marino, K.; Bones, J.; Kattla, J.J.; Rudd, P.M. A systematic approach to protein glycosylation analysis: A path through the maze. Nat. Chem. Biol. 2010, 6, 713-723.
24. Yue, T.; Haab, B.B. Microarrays in glycoproteomics research. Clin. Lab. Med. 2009, 29, 15-29.
25. Saldova, R.; Wormald, M.R.; Dwek, R.A.; Rudd, P.M. Glycosylation changes on serum glycoproteins in ovarian cancer may contribute to disease pathogenesis. Dis. Markers 2008, 25, 219-232.
26. Saldova, R.; Royle, L.; Radcliffe, C.M.; Abd Hamid, U.M.; Evans, R.; Arnold, J.N.; Banks, R.E.; Hutson, R.; Harvey, D.J.; Antrobus, R.; et al. Ovarian cancer is associated with changes in glycosylation in both acute-phase proteins and IgG. Glycobiology 2007, 17, 1344-1356.
27. Brockhausen, I. Pathways of O-glycan biosynthesis in cancer cells. Biochim. Biophys. Acta 1999, 1473, 67-95.
28. Tsuboi, S.; Hatakeyama, S.; Ohyama, C.; Fukuda, M. Two opposing roles of O-glycans in tumor metastasis. Trends Mol. Med. 2012, 18, 224-232.
29. Laemmli, U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227, 680-685.
30. Huang, Y.; Mechref, Y.; Novotny, M.V. Microscale nonreductive release of O-linked glycans for subsequent analysis through MALDI mass spectrometry and capillary electrophoresis. Anal. Chem. 2001, 73, 6063-6069.
31. Bigge, J.C.; Patel, T.P.; Bruce, J.A.; Goulding, P.N.; Charles, S.M.; Parekh, R.B. Nonselective and efficient fluorescent labeling of glycans using 2-amino benzamide and anthranilic acid. Anal. Biochem. 1995, 230, 229-238.
32. Royle, L.; Radcliffe, C.M.; Dwek, R.A.; Rudd, P.M. Detailed structural analysis of N-glycans released from glycoproteins in SDS-PAGE gel bands using HPLC combined with exoglycosidase array digestions. Methods Mol. Biol. 2006, 347, 125-143.
33. Royle, L.; Mattu, T.S.; Hart, E.; Langridge, J.I.; Merry, A.H.; Murphy, N.; Harvey, D.J.; Dwek, R.A.; Rudd, P.M. An analytical and structural database provides a strategy for sequencing O-glycans from microgram quantities of glycoproteins. Anal. Biochem. 2002, 304, 70-90.
34. Harvey, D.J. Fragmentation of negative ions from carbohydrates: Part 2. Fragmentation of high-mannose N-linked glycans. J. Am. Soc. Mass Spectrom. 2005, 16, 631-646.
35. Harvey, D.J. Fragmentation of negative ions from carbohydrates: Part 1. Use of nitrate and other anionic adducts for the production of negative ion electrospray spectra from N-linked carbohydrates. J. Am. Soc. Mass Spectrom. 2005, 16, 622-630.
36. Harvey, D.J. Fragmentation of negative ions from carbohydrates: Part 3. Fragmentation of hybrid and complex N-linked glycans. J. Am. Soc. Mass Spectrom. 2005, 16, 647-659.
37. Harvey, D.J.; Royle, L.; Radcliffe, C.M.; Rudd, P.M.; Dwek, R.A. Structural and quantitative analysis of N-linked glycans by matrix-assisted laser desorption ionization and negative ion nanospray mass spectrometry. Anal. Biochem. 2008, 376, 44-60.
38. Marino, K.; Saldova, R.; Adamczyk, B.; Rudd, P.M. Changes in serum N-glycosylation profiles: Functional significance and potential for diagnostics. Carbohydr. Chem. 2012, 37, 57-93.
39. Arnold, J.N.; Saldova, R.; Galligan, M.C.; Murphy, T.B.; Mimura-Kimura, Y.; Telford, J.E.; Godwin, A.K.; Rudd, P.M. Novel biomarkers for the detection of lung cancer. J. Proteome Res. 2011, 10, 1755-1764.
40. Miyoshi, E.; Shinzaki, S.; Moriwaki, K.; Matsumoto, H.; Minoru, F. Identification of fucosylated haptoglobin as a novel tumor marker for pancreatic cancer and its possible application for a clinical diagnostic test. Methods Enzymol. 2010, 478, 153-164.
41. Pierce, A.; Saldova, R.; Abd Hamid, U.M.; Abrahams, J.L.; McDermott, E.W.; Evoy, D.; Duffy, M.J.; Rudd, P.M. Levels of specific glycans significantly distinguish lymph node-positive from lymph node-negative breast cancer patients. Glycobiology 2010, 20, 1283-1288.
42. Chen, K.; Gentry-Maharaj, A.; Burnell, M.; Steentoft, C.; Marcos-Silva, L.; Mandel, U.; Jacobs, I.; Dawnay, A.; Menon, U.; Blixt, O. microarray Glycoprofiling of CA125 improves differential diagnosis of ovarian cancer. J. Proteome Res. 2013, 12, 1408-1418.
43. Domon, B.; Costello, C.E. A systematic nomenclature for carbohydrate fragmentations in FAB-MS/MS spectra of glycoconjugates. Glycoconj. J. 1988, 5, 397-409.